13D Filing: Levin Capital Strategies and Fluidigm Corp (FLDM)

Page 11 of 18

Page 11 of 18 – SEC Filing

The following constitutes
Amendment No. 3 to the Schedule 13D filed by the undersigned (the “Amendment No. 3”). This Amendment No. 3 amends the
Schedule 13D as specifically set forth herein.

ITEM 2. IDENTITY AND BACKGROUND

Item 2 is hereby
amended to add the following:

Effective February
28, 2018, Levin Capital Trilogy Master Fund, Ltd. changed its name to Bi-Directional Disequilibrium Master Fund, Ltd. (“Bi-Directional”).

ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.

Item 3 is hereby
amended and restated as follows:

The Shares
purchased by LCS on behalf of separately managed accounts, including Transamerica Large Cap Value Fund, a registered
investment company under the Investment Company Act of 1940, as amended (“Transamerica”), for which LCS acts as
sub-investment advisor, were purchased with general investment funds in open market purchases, except as otherwise noted. The
aggregate purchase price of the 12,258,233 Shares held in separately managed accounts that are beneficially owned directly by
LCS is approximately $60,347,703, including brokerage commissions.

The Shares purchased
by Bi-Directional were purchased with general investment funds in open market purchases, except as otherwise noted. The aggregate
purchase price of the 89,363 Shares owned directly by Bi-Directional is approximately $544,787,
i
ncluding brokerage commissions.

The Shares purchased
by Levcap were purchased with general investment funds in open market purchases, except as otherwise noted. The aggregate purchase
price of the 56,820 Shares owned directly by Levcap is approximately $280,825, including brokerage commissions.

The Shares purchased
by Safinia were purchased with general investment funds in open market purchases, except as otherwise noted. The aggregate purchase
price of the 19,818 Shares owned directly by Safinia is approximately $107,616, including brokerage commissions.

The Shares purchased
by John Levin’s wife were purchased with general investment funds in open market purchases, except as otherwise noted. The
aggregate purchase price of the 5,000 Shares owned directly by John Levin’s wife is approximately $39,359, including brokerage
commissions.

To the best of the
Reporting Persons’ knowledge, none of the persons listed on Appendix A beneficially owns any securities of the Issuer.

ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.

Items 5(a)-(d) are
hereby amended and restated as follows:

The aggregate percentage
of Shares reported owned by each person named herein is based upon 38,647,687 Shares outstanding, which is the total number of
Shares outstanding as reported in the Issuer’s Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission
on November 7, 2017.

11

Follow Standard Biotools Inc. (NASDAQ:LAB)

Page 11 of 18